Revvity is a global leader in developing and delivering technologies and solutions across disease pathways, focused on advancing health science and human potential. They develop cutting-edge technologies in areas like biomarker identification, multi-omics, diagnostics, and informatics, supporting critical processes from disease research to diagnostics and treatment. Serving over 2 million scientists and operating in 190 countries, Revvity aims to accelerate scientific breakthroughs that address significant health challenges.
Tackling the Climate and Nature Emergency Will Require Politicians to Work Across Party Lines in the 21st Century
Chair of the Environment APPG, Alistair Strathern MP, writes for Chamber UK on the importance of working with partners across political parties, to create consensus, tackle climate change and renew ambition and action for climate and environmental leadership